1. Home
  2. IDYA vs CSTM Comparison

IDYA vs CSTM Comparison

Compare IDYA & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.39

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$24.70

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
CSTM
Founded
2015
2010
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
IDYA
CSTM
Price
$32.39
$24.70
Analyst Decision
Strong Buy
Buy
Analyst Count
14
2
Target Price
$49.67
$23.50
AVG Volume (30 Days)
858.2K
1.5M
Earning Date
02-13-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
$214,834,000.00
$7,969,000,000.00
Revenue This Year
$2,688.43
$9.76
Revenue Next Year
N/A
$8.10
P/E Ratio
N/A
$31.38
Revenue Growth
5377.66
11.22
52 Week Low
$13.45
$7.33
52 Week High
$39.28
$25.15

Technical Indicators

Market Signals
Indicator
IDYA
CSTM
Relative Strength Index (RSI) 41.60 67.13
Support Level $31.54 $23.27
Resistance Level $34.66 $25.01
Average True Range (ATR) 1.38 0.98
MACD -0.32 0.02
Stochastic Oscillator 16.84 83.75

Price Performance

Historical Comparison
IDYA
CSTM

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: